- Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

IllinoisVentures GP, LLC

2. Date of Event Requiring Statement (MM/DD/YYYY) 8/10/2012

3. Issuer Name and Ticker or Trading Symbol

CORTEX PHARMACEUTICALS INC/DE/ [CORX]

(Last) (First) (Middle)

20 NORTH WACKER, SUITE 1201

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___ X ___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

CHICAGO, IL 60606

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, par value $0.001 per share	20334546	I ⁽¹⁾	See Footnote 1

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

( 1)

Shares listed are directly held by Illinois Emerging Technologies Fund, LP ("IETF"), the general partner of which is IllinoisVentures GP, LLC (the "General Partner"). The General Partner may be deemed an indirect beneficial owner of the shares held by IETF. Pursuant to Rule 16a-1(a)(4) promulgated under the Exchange Act of 1934, as amended, the General Partner disclaims its beneficial ownership of such shares, except to the extent of its pecuniary interest.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
IllinoisVentures GP, LLC 20 NORTH WACKER SUITE 1201 CHICAGO, IL 60606		X
ILLINOIS EMERGING TECHNOLOGIES FUND LP 20 NORTH WACKER, SUITE 1201 CHICAGO, IL 60606		X

Signatures
/s/ John Banta, Managing Principal		8/20/2012
^** Signature of Reporting Person		Date
/s/ John Banta, Managing Principal, IllinoisVentures GP, LLC, its general partner		8/20/2012
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.